Retinal Degeneration Gene Panel Test
About Retinal Degeneration Gene Panel Test
| Field | Value |
|---|---|
| Also Known As | Inherited Retinal Dystrophy (IRD) Gene Panel, Retinal Dystrophy Panel, IRD Panel, Inherited Retinal Disease Genetic Test |
| Sample Type | Chorionic villus (CVS), amniotic fluid, or peripheral blood (EDTA tube) |
| Fasting Required | No fasting required |
| Report Time | 35 days |
| Recommended For | All ages; individuals with suspected inherited retinal disease, regardless of gender |
| Price | Starting at ₹21,600 |
What is a Retinal Degeneration Gene Panel Test?
The retinal degeneration gene panel test is a specialised genetic test that analyses multiple genes linked to inherited retinal diseases. A doctor may order it when a patient shows signs of progressive vision loss or other features that suggest a hereditary eye condition. Also known as the Inherited Retinal Dystrophy (IRD) Panel, it uses next-generation sequencing (NGS) to examine DNA from a blood, chorionic villus, or amniotic fluid sample. The test helps confirm or clarify a clinical diagnosis when physical examination alone is not sufficient.
What Does a Retinal Degeneration Gene Panel Test Measure?
This test scans a large number of genes known to be associated with inherited retinal conditions. The table below lists the key genes assessed and their significance.
| Gene | Association |
|---|---|
| ABCA4 | Stargardt disease and cone-rod dystrophy; the most commonly implicated gene in inherited retinal disease |
| USH2A | Usher syndrome and retinitis pigmentosa (a condition causing gradual loss of peripheral vision) |
| RPGR | X-linked retinitis pigmentosa |
| RPE65 | Visual cycle function; variants in this gene may make a patient eligible for approved gene therapy |
| EYS, RHO, PRPH2, BEST1 | Various forms of retinal dystrophy and macular degeneration |
| RS1, RP1, CHM, CRB1, PRPF31, MYO7A, OPA1 | Additional genes associated with a range of inherited retinal disorders |
Beyond identifying specific gene variants, the test classifies each finding as pathogenic, likely pathogenic, a variant of uncertain significance (VUS), or benign.
Why is a Retinal Degeneration Gene Panel Test Done?
A doctor may request this test when a patient's clinical picture points to an inherited retinal disorder. It is also used to guide family planning decisions and assess eligibility for emerging treatments.
Common Symptoms That May Require This Test
The following symptoms are among the most common reasons a doctor may refer a patient for retinal degeneration gene panel testing:
- Night blindness or difficulty seeing in low light
- Progressive loss of peripheral (side) vision or tunnel vision
- Gradual decline in central or overall vision
- Colour blindness or difficulty distinguishing colours
- Nystagmus (involuntary, repetitive eye movements)
- Increased sensitivity to bright light (photophobia)
- Unexplained dimness or blurring of vision
Conditions This Test Can Help Detect
This test can help identify a range of inherited retinal conditions, including:
- Retinitis pigmentosa
- Leber congenital amaurosis
- Stargardt disease
- Best macular dystrophy
- Cone-rod dystrophy
- Achromatopsia (total colour blindness)
- Congenital stationary night blindness
- Usher syndrome, Bardet-Biedl syndrome, Senior-Loken syndrome, and Joubert syndrome
How to Prepare and What to Expect
Preparing for this test is straightforward, but a few steps help ensure a reliable sample and a smooth experience.
Do You Need to Fast?
No fasting is required before this test. You may eat and drink as normal on the day of sample collection.
Practical Tips Before Your Test
Keep the following points in mind before attending your appointment:
- Bring a detailed clinical history, including your symptoms, previous eye examination reports, imaging results, and family history of eye conditions, as this is required for the test.
- Inform the laboratory of any prior genetic tests you have undergone.
- If providing a saliva sample, avoid eating, drinking, smoking, or chewing gum for at least 30 minutes beforehand.
- Attend a pre-test genetic counselling session to understand the scope, limitations, and implications of the test.
- Wear comfortable clothing with easy access to the forearm if a blood draw is needed.
Step-by-Step Procedure
This test accepts three sample types. The collection process for each is described below.
Peripheral Blood Sample:
- A trained phlebotomist cleans the skin on your inner arm and draws a small blood sample (3 ml) into a lavender-topped EDTA tube.
- The tube is labelled and stored at 2 to 8°C for transport to the laboratory.
- DNA is extracted from the blood cells in the laboratory.
Chorionic Villus Sample (CVS):
- A specialist collects a small tissue sample (30 mg) from the placenta using a thin needle or catheter, under imaging guidance, in a clinical setting.
- The sample is placed in a sterile white container and kept refrigerated at 2 to 8°C during transport.
- DNA is extracted from the tissue in the laboratory.
Amniotic Fluid Sample:
- A specialist performs an amniocentesis procedure, drawing 20 ml of amniotic fluid using a thin needle inserted through the abdomen, under imaging guidance.
- The fluid is collected in a dedicated Falcon tube (white) and stored at 2 to 8°C during transit.
- DNA is isolated from cells present in the fluid.
For all sample types, the extracted DNA is then analysed using NGS methods. Results are reviewed by a clinical geneticist, and a report is prepared. The turnaround time is 35 days.
Factors That Can Affect Accuracy
Several factors can influence how complete or conclusive the results are:
- Poor DNA quality or insufficient sample volume
- Complex structural rearrangements (such as inversions or translocations) in the genome, which standard NGS may not detect
- Lower sequencing coverage in certain repetitive gene regions
- Genes not yet linked to retinal disease in the scientific literature will not be included in the panel
Understanding Your Retinal Degeneration Gene Panel Test Results
Results from this test are reported in categories rather than numerical ranges. A genetic counsellor or medical geneticist should always review findings alongside your clinical history.
| Result Category | Meaning |
|---|---|
| Pathogenic / Likely pathogenic | A disease-causing mutation has been identified in a known retinal disease gene |
| Variant of uncertain significance (VUS) | A change was found, but its clinical significance is currently unclear; may need periodic reassessment |
| Benign / Likely benign | The variant identified is not associated with retinal disease |
| No pathogenic variant detected | No known disease-causing change found; this does not rule out a genetic cause if the relevant gene is not yet discovered |
Approximately 6 in 10 individuals tested receive a definitive genetic diagnosis (a genetically solved rate of around 61% across studies).
Disclaimer: These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
How to Maintain Healthy Levels
While genetic variants cannot be changed, the following general habits support eye health:
- Attend regular follow-up appointments with a retinal specialist to monitor any vision changes.
- Wear good-quality sunglasses outdoors to protect the eyes from UV exposure.
- Speak with your doctor about whether any nutritional supplements may be appropriate for your eye health.
Lupin Diagnostics Retinal Degeneration Gene Panel Test Price
The retinal degeneration gene panel test cost at Lupin Diagnostics starts at ₹21,600. This test requires a visit to a Lupin Diagnostics centre; home collection is not available for this test.
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 21600 |
| CHENNAI | 21600 |
| HYDERABAD | 21600 |
| KOLKATA | 21600 |
| NAVI MUMBAI | 21600 |
| PUNE | 21600 |
Disclaimer: Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Follow these steps to book your retinal degeneration gene panel test online:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred centre location.
- Visit the centre at your scheduled time for sample collection.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Frequently Asked Questions
This test identifies genetic mutations in genes linked to inherited retinal diseases. It helps confirm conditions such as retinitis pigmentosa, Stargardt disease, and Leber congenital amaurosis when clinical examination alone cannot provide a clear answer. The findings can also guide family testing and assess access to available therapies.
At Lupin Diagnostics, this test is performed on three sample types: a chorionic villus sample, amniotic fluid, or a peripheral blood sample collected in an EDTA tube. Your doctor will advise which sample type is appropriate for your situation.
Yes, genetic counselling is strongly recommended before proceeding. A counsellor will explain what the test can and cannot detect, discuss potential results, and help you understand what findings may mean for you and your family members.
The report for the retinal degeneration gene panel test at Lupin Diagnostics is delivered within 35 days. This allows time for full NGS analysis and expert review of the findings.
Not always. Studies show that approximately 6 in 10 individuals receive a definitive genetic diagnosis. In remaining cases, the causative mutation may lie in a gene not yet associated with retinal disease, or in a region not fully covered by the current panel.
Genetic results from a retinal degeneration gene panel must be interpreted alongside your clinical presentation. Information such as symptoms, age of onset, family history, and prior eye examination findings helps the geneticist decide whether a detected variant is relevant to your condition.
For some genetic findings, treatment options exist. For example, patients with mutations in the RPE65 gene may be eligible for voretigene neparvovec (Luxturna), an approved gene therapy. Clinical trials targeting other genes, such as RPGR and USH2A, are also underway. Your doctor or genetic counsellor can advise on options relevant to your specific result.
Retinal Degeneration Gene Panel Test
